跳至主要内容
临床试验/NL-OMON55200
NL-OMON55200已完成不适用

Biomarker-based Early Anti-inflammatory Therapy for severe COVID-19 - BEAT-COVID-1

eids Universitair Medisch Centrum0 个研究点目标入组 275 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
275

研究概览

简要总结

Trial ended prematurely

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • hospitalized patients
  • - Hospitalized patient with PCR confirmed COVID-19 infection
  • - Eighteen years or older
  • healthy volunteers
  • - Not-hospitalized
  • - Sixty years or older
  • - Sars-CoV-2 serology negative
  • mild infection
  • - Positive SARS-CoV-2 PCR test from the GGD
  • - No or limited symptoms of a viral airway infection (fever, cough, dyspnea,
  • rhinorroea, myalgia, anosmia) at the time of inclusion
  • - Age 18 years or older

排除标准

  • Patients and healthy controls
  • - Not able to give consent by the healthy volunteer, or the patient or patients
  • representative
  • Healthy controls
  • - Symptoms of viral airway infection (e.g. fever, cough, rhinorroea,
  • dyspnea) at screening or inclusion
  • Group of infected individuals with little or no symptoms:
  • - Having received vaccination against SARS-CoV-2 or previous confirmed
  • infection with SARS-CoV-2.
  • - Not being able to come to LUMC by own transportation to donate samples.

研究者

相似试验